Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Minoru Nomoto is active.

Publication


Featured researches published by Minoru Nomoto.


Cancer Treatment Reviews | 2003

Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy

Hiroto Izumi; Takayuki Torigoe; Hiroshi Ishiguchi; Hidetaka Uramoto; Yoichiro Yoshida; Mizuho Tanabe; Tomoko Ise; Tadashi Murakami; Takeshi Yoshida; Minoru Nomoto; Kimitoshi Kohno

One of the major obstacles to the successful treatment of cancer is the complex biology of solid tumour development. Although regulation of intracellular pH has been shown to be critically important for many cellular functions, pH regulation has not been fully investigated in the field of cancer. It has, however, been shown that cellular pH is crucial for biological functions such as cell proliferation, invasion and metastasis, drug resistance and apoptosis. Hypoxic conditions are often observed during the development of solid tumours and lead to intracellular and extracellular acidosis. Cellular acidosis has been shown to be a trigger in the early phase of apoptosis and leads to activation of endonucleases inducing DNA fragmentation. To avoid intracellular acidification under such conditions, pH regulators are thought to be up-regulated in tumour cells. Four major types of pH regulator have been identified: the proton pump, the sodium-proton exchanger family (NHE), the bicarbonate transporter family (BCT) and the monocarboxylate transporter family (MCT). Here, we describe the structure and function of pH regulators expressed in tumour tissue. Understanding pH regulation in tumour cells may provide new ways of inducing tumour-specific apoptosis, thus aiding cancer chemotherapy.


Gene | 2000

Cell-cycle regulation of the DNA topoisomerase IIα promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation

Noritaka Adachi; Minoru Nomoto; Kimitoshi Kohno; Hideki Koyama

Expression of DNA topoisomerase (topo) IIalpha is cell-cycle-regulated, with its peak in G(2)/M and its lowest level in G(0)/G(1). In agreement with this expression pattern, we have shown that the topo IIalpha gene promoter shows cell-cycle-dependent activity, which is repressed in G(0)/G(1) and activated exclusively in G(2)/M. However, the promoter sequence reveals no canonical CDE/CHR motifs, repressor elements commonly found in promoters of late S/G(2)-activated genes. Here, we show that at least two of the three proximal inverted CCAAT boxes (ICBs) are responsible for the G(2)/M-specific activation of the topo IIalpha promoter. Using antibody supershift experiments, we identify NF-Y as the ICB-binding transcription factor. However, the expression profile and binding capacity of NF-Y were constant during the cell cycle, suggesting a more global mechanism in topo IIalpha promoter regulation. Interestingly, we find that trichostatin A (TSA), a specific histone deacetylase inhibitor, greatly enhances topo IIalpha promoter activity in an ICB-dependent manner. In addition, the effect of TSA is predominant in G(0)/G(1) and less obvious in G(2)/M. Our data, along with the recent findings that NF-Y associates in vivo with histone acetyltransferases (HATs), strongly suggest a mechanism, in which histone deacetylation plays a crucial role in the G(0)/G(1)-specific repression of the topo IIalpha promoter, and NF-Y recruits HATs to the promoter region, thereby stimulating histone acetylation and activating transcription in G(2)/M.


Cancer | 2002

Expression of UDP-N-acetyl-α-D-galactosamine–polypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma

Kazunori Shibao; Hiroto Izumi; Yoshifumi Nakayama; Ryo Ohta; Naoki Nagata; Minoru Nomoto; Ken-ichi Matsuo; Yuji Yamada; Kenji Kitazato; Hideaki Itoh; Kimitoshi Kohno

Tumor development usually is accompanied by alterations of O‐glycosylation. Initial glycosylation of mucin‐type, O‐linked proteins is catalyzed by one of the UDP‐GalNAc–polypeptide N‐acetyl‐galactosaminyl transferases, such as GalNAc‐T3, which is expressed in adenocarcinoma cells. The authors investigated whether such expression influenced tumor differentiation or prognosis in patients with colorectal carcinoma.


Anti-Cancer Drugs | 2002

Vacuolar H(+)-ATPase: functional mechanisms and potential as a target for cancer chemotherapy.

Takayuki Torigoe; Hiroto Izumi; Tomoko Ise; Tadashi Murakami; Hidetaka Uramoto; Hiroshi Ishiguchi; Yoichiro Yoshida; Mizuho Tanabe; Minoru Nomoto; Kimitoshi Kohno

Tumor cells in vivo often exist in a hypoxic microenvironment with a lower extracellular pH than that surrounding normal cells. Ability to upregulate proton extrusion may be important for tumor cell survival. Such microenvironmental factors may be involved in the development of resistant subpopulations of tumor cells. In solid tumors, both intracellular and extracellular pH differ between drug-sensitive and -resistant cells, and pH appears critical to the therapeutic effectiveness of anticancer agents. Four major types of pH regulators have been identified in tumor cells: the sodium–proton antiporter, the bicarbonate transporter, the proton–lactate symporter and proton pumps. Understanding mechanisms regulating tumor acidity opens up novel opportunities for cancer chemotherapy. In this minireview, we describe the structure and function of certain proton pumps overexpressed in many tumors—vacuolar H+-ATPases—and consider their potential as targets for cancer chemotherapy.


Biochemical Journal | 2003

p300/CBP-associated factor (P/CAF) interacts with nuclear respiratory factor-1 to regulate the UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase-3 gene.

Hiroto Izumi; Ryo Ohta; Gunji Nagatani; Tomoko Ise; Yoshifumi Nakayama; Minoru Nomoto; Kimitoshi Kohno

We demonstrated recently that expression of the UDP- N -acetyl-alpha-D-galactosamine: polypeptide N -acetylgalactosaminyltrans-ferase-3 (GalNAc-T3) gene is restricted to epithelial glands [Nomoto, Izumi, Ise, Kato, Takano, Nagatani, Shibao, Ohta, Imamura, Kuwano, Matsuo, Yamada, Itoh and Kohno (1999) Cancer Res. 59, 6214-6222]. In the present study, we show that sodium butyrate treatment of human breast cancer MCF-7 cells transcriptionally activates the GalNAc-T3 gene. Transient transfection of plasmids containing a reporter gene under the control of GalNAc-T3 indicated that several transcriptional elements are involved in response to sodium butyrate, with the nuclear respiratory factor-1 (NRF-1)-binding motif located between -88 and -77nt being the most important. Incubation of a labelled probe encompassing the NRF-1-binding motif with a nuclear extract of sodium butyrate-treated MCF-7 cells yielded a higher level of specific DNA-protein complex versus controls. Flag-tagged NRF-1 expressed in MCF-7 cells can bind to the NRF-1-binding motif of the GalNAc-T3 promoter. Nuclear content of NRF-1 remained constant in MCF-7 cells treated with or without sodium butyrate. Moreover, NRF-1 interacts with and is acetylated by p300/CBP-associated factor (P/CAF). Acetylation of NRF-1 enhances DNA binding. Co-transfection of the GalNAc-T3 reporter plasmid with either NRF-1 or P/CAF expression plasmid resulted in the activation of the GalNAc-T3 promoter. These results indicate a correlation between acetylation of NRF-1 by P/CAF and the butyrate-induced expression of the GalNAc-T3 gene. Additionally, induced expression of P/CAF may be a component of the adenocarcinoma differentiation process.


Biochimica et Biophysica Acta | 1995

Analysis of cis-acting regions upstream of the rat Na+/K+-ATPase α1 subunit gene by in vivo footprinting

Minoru Nomoto; Frank J. Gonzalez; Takashi Mita; Nobuo Inoue; Masaru Kawamura

By means of in vivo footprinting, we examined the putative cis-acting DNA elements located between -50 and -122 of rat Na+/K(+)-ATPase alpha 1 subunit gene ATP1A1. Proximal and distal GC box sequences and a consensus sequence for the active transcription factor (ATF) were protected for all the tissues examined (kidney, brain and liver). Putative cooperation between two binding factors on the ATF site and the proximal GC box was observed. The overall in vivo footprinting profiles of the three tissues did not exhibit any marked differences that could account for the variation in the extent of tissue-specific transcription. The alpha 1 regulatory element (ARE) found by Suzuki-Yagawa et al. does not appear to be an element responsible for tissue-specific regulation of the gene.


Oncogene | 2002

Relations between clusters of oxidatively damaged nucleotides and active or open nucleosomes in the rat Nth 1 gene.

Minoru Nomoto; Raizo Yamaguchi; Kimitoshi Kohno; Hiroshi Kasai

The distribution of oxidative damage to bases such as 8-hydroxyguanine (8-OH-Gua), was determined at the nucleotide level of resolution using the ligation-mediated PCR technique. Administration of a renal carcinogen, ferric nitrilotriacetate (Fe-NTA), is known to induce oxidative stress and subsequent formation of 8-OH-Gua in the kidney. Whole genomic DNA was isolated from the rat kidney with or without Fe-NTA treatment and then digested with formamidopyrimidine-DNA glycosylase (Fpg). As a target, we focused on the gene of a DNA repair enzyme for thymine glycol, Nth 1. Cleaved signals were found in exon 1 and exon 3, but not exon 5. Nucleosomes in these regions, enriched in damaged nucleotides, were highly accessible to micrococcal nuclease, especially in the kidney. Taking into account the function of the protein segment encoded by these regions, we discussed the molecular mechanism of the restricted formation of the damaged nucleotides.


Cancer Research | 1999

Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen.

Tomoko Ise; Gunji Nagatani; Toshihiro Imamura; Ken Kato; Hiroshi Takano; Minoru Nomoto; Hiroto Izumi; Haruki Ohmori; Tatsuro Okamoto; Takefumi Ohga; Takeshi Uchiumi; Michihiko Kuwano; Kimitoshi Kohno


Nucleic Acids Research | 2001

Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3′→5′ exonuclease activity

Hiroto Izumi; Toshihiro Imamura; Gunji Nagatani; Tomoko Ise; Tadashi Murakami; Hidetaka Uramoto; Takayuki Torigoe; Hiroshi Ishiguchi; Yoichiro Yoshida; Minoru Nomoto; Tatsuro Okamoto; Takeshi Uchiumi; Michihiko Kuwano; Keiko Funa; Kimitoshi Kohno


Journal of Biological Chemistry | 2002

Enhanced Expression of the Human Vacuolar H+-ATPase c subunit Gene (ATP6L) in Response to Anticancer Agents

Takayuki Torigoe; Hiroto Izumi; Hiroshi Ishiguchi; Hidetaka Uramoto; Tadashi Murakami; Tomoko Ise; Yoichiro Yoshida; Mizuho Tanabe; Minoru Nomoto; Hideaki Itoh; Kimitoshi Kohno

Collaboration


Dive into the Minoru Nomoto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tomoko Ise

University of Gothenburg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge